COJOCARU, S., RUSSU, I., BUTA, G., BERSAN, S., POTÎNG-RAȘCOV, V., CULIUC, N., & BABA, L. (2023). A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease. One Health & Risk Management , 4(4), 19-26. https://doi.org/10.38045/ohrm.2023.4.02